Valuation: Consort Medical plc

Market Cap 502M 440M 416M 379M 710M 48.11B 715M 4.98B 1.93B 24.58B 1.88B 1.84B 78.99B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 526M 497M 453M 847M 57.44B 853M 5.94B 2.3B 29.35B 2.25B 2.2B 94.31B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 46 2023-01-31
Director/Board Member 52 2024-03-31
Director/Board Member 53 2024-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
2/6/20 Sell 211,474 0.4284%
2/6/20 Exercice 211,474 0.4284%
2/6/20 Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
+0.22%-1.29%-24.16%+5.26% 175B
+0.97%-3.79%-5.92%+12.27% 113B
-0.95%-0.60%-0.03%+65.22% 58.57B
+2.56%+1.59%-0.42%-29.55% 50.07B
+1.49%+3.89%+15.12%+53.65% 49.92B
-0.97%-3.06%+29.09%-2.26% 32.69B
+0.12%+9.67% - - 30.44B
-0.85%+2.24%+41.65%-1.32% 26.07B
-1.58%+7.22%+23.81%-6.14% 23.55B
Average +0.10%+1.60%+9.89%+12.14% 56.06B
Weighted average by Cap. +0.37%-0.00%-2.98%+13.37%

Financials

2018 2019
Net sales 311M 273M 258M 235M 440M 29.82B 443M 3.09B 1.19B 15.23B 1.17B 1.14B 48.96B 305M 268M 253M 230M 431M 29.24B 434M 3.03B 1.17B 14.94B 1.15B 1.12B 48.01B
Net income 16.1M 14.13M 13.34M 12.16M 22.76M 1.54B 22.92M 160M 61.84M 788M 60.45M 59.14M 2.53B 10.5M 9.21M 8.7M 7.93M 14.85M 1.01B 14.95M 104M 40.33M 514M 39.42M 38.57M 1.65B
Net Debt 95.5M 83.8M 79.15M 72.13M 135M 9.15B 136M 947M 367M 4.68B 359M 351M 15.03B 97.4M 85.47M 80.72M 73.56M 138M 9.34B 139M 966M 374M 4.77B 366M 358M 15.33B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock